Executive Director, Biocom California
Stephanie Hsieh is executive director of Biocom California, a non-profit trade association for the life science industry, and a board member of Meditope Biosciences, Inc., a privately held preclinical stage immuno-oncology company.
Stephanie most recently served as CEO of Meditope Biosciences, growing the company from academic discovery to preclinical stage oncology, with a focused, yet diversified portfolio of immuno-therapy and oncology assets. In this capacity, Stephanie set strategic and commercial directions, securing the exclusive rights to the technology, as well as its Series A financing and pharma partnerships, and earned a reputation for operational excellence, including management of challenging P&Ls.
